tissue engineering presentation
TRANSCRIPT
![Page 1: TIssue engineering presentation](https://reader033.vdocuments.mx/reader033/viewer/2022052601/558a37ded8b42ab91d8b4586/html5/thumbnails/1.jpg)
PEDIATRIC CARDIAC defects
!ssue engineering solutions for
presented by Poppy Addison
![Page 2: TIssue engineering presentation](https://reader033.vdocuments.mx/reader033/viewer/2022052601/558a37ded8b42ab91d8b4586/html5/thumbnails/2.jpg)
1 2 3 4
CONGENITAL DEFECTS
Current treatment
GOALS of TREATMENT
FUTURE TREATMENTS
![Page 3: TIssue engineering presentation](https://reader033.vdocuments.mx/reader033/viewer/2022052601/558a37ded8b42ab91d8b4586/html5/thumbnails/3.jpg)
1 2 3 4
CONGENITAL DEFECTS
Current treatment
GOALS of TREATMENT
FUTURE TREATMENTS
![Page 4: TIssue engineering presentation](https://reader033.vdocuments.mx/reader033/viewer/2022052601/558a37ded8b42ab91d8b4586/html5/thumbnails/4.jpg)
1% of newborns are affected
![Page 5: TIssue engineering presentation](https://reader033.vdocuments.mx/reader033/viewer/2022052601/558a37ded8b42ab91d8b4586/html5/thumbnails/5.jpg)
ventricular septaL defect
for instance,
![Page 6: TIssue engineering presentation](https://reader033.vdocuments.mx/reader033/viewer/2022052601/558a37ded8b42ab91d8b4586/html5/thumbnails/6.jpg)
1 2 3 4
CONGENITAL DEFECTS
Current treatment
GOALS of TREATMENT
FUTURE TREATMENTS
![Page 7: TIssue engineering presentation](https://reader033.vdocuments.mx/reader033/viewer/2022052601/558a37ded8b42ab91d8b4586/html5/thumbnails/7.jpg)
SURGERIES multi-stage high-risk
![Page 8: TIssue engineering presentation](https://reader033.vdocuments.mx/reader033/viewer/2022052601/558a37ded8b42ab91d8b4586/html5/thumbnails/8.jpg)
1 2 3 4
CONGENITAL DEFECTS
Current treatment
GOALS of TREATMENT
FUTURE TREATMENTS
![Page 9: TIssue engineering presentation](https://reader033.vdocuments.mx/reader033/viewer/2022052601/558a37ded8b42ab91d8b4586/html5/thumbnails/9.jpg)
1. 2. 3. 4.
GROW INTEGRATE Avoid
Be cheap & FAST
immun4uppression & open-heart surgery
![Page 10: TIssue engineering presentation](https://reader033.vdocuments.mx/reader033/viewer/2022052601/558a37ded8b42ab91d8b4586/html5/thumbnails/10.jpg)
1 2 3 4
CONGENITAL DEFECTS
Current treatment
GOALS of TREATMENT
FUTURE TREATMENTS
![Page 11: TIssue engineering presentation](https://reader033.vdocuments.mx/reader033/viewer/2022052601/558a37ded8b42ab91d8b4586/html5/thumbnails/11.jpg)
embryonic stem cells vs INDUCED STEM CELLS vs INDUCED CARDIOMYOCYTES ✓
![Page 12: TIssue engineering presentation](https://reader033.vdocuments.mx/reader033/viewer/2022052601/558a37ded8b42ab91d8b4586/html5/thumbnails/12.jpg)
SCAFFOLD VS NO SCAFFOLD ✓
![Page 13: TIssue engineering presentation](https://reader033.vdocuments.mx/reader033/viewer/2022052601/558a37ded8b42ab91d8b4586/html5/thumbnails/13.jpg)
Bioreactor ✓
![Page 14: TIssue engineering presentation](https://reader033.vdocuments.mx/reader033/viewer/2022052601/558a37ded8b42ab91d8b4586/html5/thumbnails/14.jpg)
5nd 5rther research in
Induced cardiomyocytes scaffold-free methods bioreactors